4751 - 4800 of 9145 Results
Title
Year
- Disease-modifying therapies for Parkinson's disease2013OPENTitle: Disease-modifying therapies for Parkinson's diseaseJournal Name: The Biomedical & Life Sciences CollectionPublisher: Henry Stewart TalksVol: 2013Issue #: 3Start Page: e1003178End Page: e1003178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.69645/krxj9755Citation Count: 0
- Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)2014RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016Citation Count: 0
- P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers2012RESTRICTEDTitle: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296Citation Count: 0
-
OPENTitle: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 7Start Page: 879End Page: 880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7533975Citation Count: 0
- No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)2013RESTRICTEDTitle: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187Citation Count: 0
- Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)2017RESTRICTEDTitle: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007Citation Count: 0
- Fox Trial Finder, un nouvel outil pour la recherche clinique2014RESTRICTEDTitle: Fox Trial Finder, un nouvel outil pour la recherche cliniqueJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 170Issue #:Start Page: A133End Page: A134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360Citation Count: 0
- O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH2018RESTRICTEDTitle: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACHJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 14Issue #: 7S_Part_11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691Citation Count: 0
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease2010RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 71
-
OPENTitle: A Culturally Tailored Community Health Worker Intervention Leads to Improvement in Patient-Centered Outcomes for Immigrant Patients With Type 2 DiabetesJournal Name: Clinical DiabetesPublisher: American Diabetes AssociationVol: 36Issue #: 2Start Page: 100End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2337/cd17-0068Best OA location URL: https://clinical.diabetesjournals.org/content/diaclin/36/2/100.full.pdfCitation Count: 61
-
OPENTitle: Feasibility of Virtual Research Visits in Fox Trial FinderJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 505End Page: 515Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150549Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150549?id=journal-of-parkinsons-disease%2Fjpd150549Citation Count: 64
-
OPENTitle: Overcoming obstacles to repurposing for neurodegenerative diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 1Issue #: 7Start Page: 512End Page: 518Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.76Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.76Citation Count: 62
-
OPENTitle: Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In VivoJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 148Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/59758Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10337163/pdf/nihms-1911472.pdfCitation Count: 56
-
OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 57
-
OPENTitle: Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin studyJournal Name: Journal of NeurochemistryPublisher: WileyVol: 149Issue #: 1Start Page: 126End Page: 138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/jnc.14569Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14569Citation Count: 56
-
OPENTitle: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 52
- Foundations for a Patient-Reported Natural History of Parkinson Disease: Cross sectional Analysis of the MJFF Fox Insight (FI) Platform (P2.056)2018RESTRICTEDTitle: Foundations for a Patient-Reported Natural History of Parkinson Disease: Cross sectional Analysis of the MJFF Fox Insight (FI) Platform (P2.056)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p2.056Citation Count: 2
- Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)2018RESTRICTEDTitle: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p3.048Citation Count: 4
- Incidence of Parkinson Disease in North America (P1-1.Virtual)2022RESTRICTEDTitle: Incidence of Parkinson Disease in North America (P1-1.Virtual)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.2665Citation Count: 3
- Announcing a New Continuing Medical Education Course2013RESTRICTEDTitle: Announcing a New Continuing Medical Education CourseJournal Name: Cognitive and Behavioral NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 26Issue #: 2Start Page: 56End Page: 58Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnn.0b013e31829af2fbCitation Count: 1
- The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)2013RESTRICTEDTitle: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049Citation Count: 2
- P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease2013RESTRICTEDTitle: P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s diseaseJournal Name: Neuromuscular DisordersPublisher: Elsevier BVVol: 23Issue #: 9-10Start Page: 836End Page: 836Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nmd.2013.06.684Citation Count: 1
- NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)2019RESTRICTEDTitle: NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-035Citation Count: 2
- At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease2018OPENTitle: At a crossroads: Revisiting mild cognitive impairment in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 501End Page: 502Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27310Citation Count: 1
- Validation of Fox Insight Cohort via Virtual Research Visits (4749)2020RESTRICTEDTitle: Validation of Fox Insight Cohort via Virtual Research Visits (4749)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4749Citation Count: 1
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities2021RESTRICTEDTitle: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunitiesJournal Name: Physiology NewsPublisher: The Physiological SocietyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.36866/pn.123.32Citation Count: 1
- The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA1967RESTRICTEDTitle: The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNAJournal Name: Arthritis & RheumatismPublisher: WileyVol: 10Issue #: 1Start Page: 32End Page: 37Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/art.1780100105Citation Count: 45
- Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)2019RESTRICTEDTitle: Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-010Citation Count: 1
- Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)2020RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 1
- Special focus section: Gene therapy for Parkinson's disease2007RESTRICTEDTitle: Special focus section: Gene therapy for Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 209Issue #: 1Start Page: 28End Page: 29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2007.09.006Citation Count: 6
- Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)2019RESTRICTEDTitle: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-011Citation Count: 0
-
OPENTitle: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience DataJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 2Start Page: e28End Page: e29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088Best OA location URL: https://doaj.org/article/33431349c85d454db7ad2af33222a015Citation Count: 0
- Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)2019RESTRICTEDTitle: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-001Citation Count: 0
-
OPENTitle: Creating a patient‐centered guide to navigating cognitive change in Parkinson’s diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.041115Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.041115Citation Count: 0
-
OPENTitle: Screening peripheral biopsies for alpha‐synuclein pathology using deep machine learningJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.047358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.047358Citation Count: 0
-
OPENTitle: Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid ImagingJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 2Issue #: 1Start Page: 57End Page: 65Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-2012-11073Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3423968Citation Count: 41
-
OPENTitle: Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian RatsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 4Issue #: 3Start Page: 349End Page: 360Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-140410Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4154985Citation Count: 138
-
OPENTitle: Parkinsonism syndrome in heterozygotes for Niemann–Pick C1Journal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 335Issue #: 1-2Start Page: 219End Page: 220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2013.08.033Best OA location URL: http://doi.org/10.1016/j.jns.2013.08.033Citation Count: 67
-
OPENTitle: Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 259Issue #: 9Start Page: 1840End Page: 1847Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-012-6419-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-012-6419-4.pdfCitation Count: 58
-
RESTRICTEDTitle: Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free AssaysJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 126Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/55361Best OA location URL: http://doi.org/10.3791/55361Citation Count: 7
-
OPENTitle: Activation of recombinant NR1/NR2C NMDA receptorsJournal Name: The Journal of PhysiologyPublisher: WileyVol: 586Issue #: 18Start Page: 4425End Page: 4439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1113/jphysiol.2008.158634Best OA location URL: http://doi.org/10.1113/jphysiol.2008.158634Citation Count: 106
- Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling2017RESTRICTEDTitle: Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and ModelingJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 123Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/55609Citation Count: 40
-
RESTRICTEDTitle: Generation of Stable Transgenic C. elegans Using MicroinjectionJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 18Start Page: 16End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/833Best OA location URL: https://www.jove.com/pdf/833/generation-of-stable-transgenic-c-elegans-using-microinjectionCitation Count: 0
-
OPENTitle: Detection of Protein UbiquitinationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 30Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/1293Best OA location URL: https://www.jove.com/pdf/1293/detection-of-protein-ubiquitinationCitation Count: 96
-
OPENTitle: Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson’s Disease and Control SubjectsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 4Start Page: 761End Page: 770Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-160888Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5501392Citation Count: 97
-
OPENTitle: Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease GenesJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/835Best OA location URL: https://www.jove.com/pdf/835/application-c-elegans-dopamine-neuron-degeneration-assay-forCitation Count: 47
-
OPENTitle: Insight into α-Synuclein Plasticity and Misfolding from Differential Micelle BindingJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 117Issue #: 39Start Page: 11448End Page: 11459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jp402589xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3946565Citation Count: 11
-
OPENTitle: Zinc inhibition of rat NR1/NR2AN‐methyl‐d‐aspartate receptorsJournal Name: The Journal of PhysiologyPublisher: WileyVol: 586Issue #: 3Start Page: 763End Page: 778Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1113/jphysiol.2007.143941Best OA location URL: http://doi.org/10.1113/jphysiol.2007.143941Citation Count: 64
-
OPENTitle: Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 1Start Page: 143End Page: 147Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-160985Best OA location URL: http://doi.org/10.3233/JPD-160985Citation Count: 11
- The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory function2012RESTRICTEDTitle: The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory functionJournal Name: The Journal of Rehabilitation Research and DevelopmentPublisher: Journal of Rehabilitation Research & DevelopmentVol: 49Issue #: 8Start Page: 1269End Page: 1269Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1682/jrrd.2011.06.0103Citation Count: 28